首页> 外文OA文献 >Blood concentrations and pharmacodynamic effects of betaxolol (SL 75212) a new beta-adrenoceptor antagonist after oral and intravenous administration.

【2h】

Blood concentrations and pharmacodynamic effects of betaxolol (SL 75212) a new beta-adrenoceptor antagonist after oral and intravenous administration.

机译：口服和静脉内给药后，一种新的β-肾上腺素能受体拮抗剂倍他洛尔（SL 75212）的血药浓度和药效学作用。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Warrington, S J; Turner, P; Kilborn, J R; Bianchetti, G; Morselli, P L;
展开▼
作者单位

展开▼
年度 1980
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Prolonged pharmacodynamic effects of S-0139, an intravenously administered endothelin A (ET) antagonist, in the human forearm blood flow model. [J] . Lunnon MW, Wallace SM, Palmer J British Journal of Clinical Pharmacology . 2010,第3期

机译：静脉注射内皮素A（ET）拮抗剂S-0139在人前臂血流模型中的药效延长。
2. Prolonged pharmacodynamic effects of S-0139, an intravenously administered endothelin A (ET_A) antagonist, in the human forearm blood flow model [J] . Martin W. Lunnon, Sharon M. L. Wallace, Joanne E. Palmer, British Journal of Clinical Pharmacology . 2010,第3期

机译：静脉注射内皮素A（ET _{A ）拮抗剂S-0139在人前臂血流模型中的药效延长}
3. Prolonged pharmacodynamic effects of S-0139, an intravenously administered endothelin A (ET_A) antagonist, in the human forearm blood flow model [J] . Martin W. Lunnon, Sharon M. L. Wallace, Joanne E. Palmer, British journal of clinical pharmacology . 2010,第3期

机译：静脉注射内皮素A（ET _{A ）拮抗剂S-0139在人前臂血流模型中的药效延长}
4. Oral Mycophenolate Mofetil Dose Escalation Trial Assessing Adverse Effects and Pharmacodynamic Responses in Normal Dogs (Abstract P14) [C] . Conference of the American College of Veterinary Internal Medicine (ACVIM) . 2017

机译：口服霉霉素Mofetil剂量升级试验评估正常狗的不利影响和药物动力学反应（摘要P14）
5. Pharmacokinetic Evaluation of a Novel Compound, SN79, a Putative Sigma-2 Receptor Antagonist, by Intravenous and Oral Administration in Rats. [D] . Vinnakota, Harsha. 2011

机译：通过大鼠静脉内和口服给药对新型化合物SN79（一种公认的Sigma-2受体拮抗剂）进行药代动力学评估。
6. Blood concentrations and pharmacodynamic effects of betaxolol (SL 75212) a new beta-adrenoceptor antagonist after oral and intravenous administration. [O] . S J Warrington, P Turner, J R Kilborn, 1980

机译：口服和静脉内给药后一种新的β-肾上腺素能受体拮抗剂倍他洛尔（SL 75212）的血药浓度和药效学作用。
7. Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocking agents betaxolol (SL 75212) in healthy volunteers. [O] . Cadigan, P J, London, D R, Pentecost, B L, 1980

机译：在健康志愿者中单次口服新的β-肾上腺素受体阻断剂倍他洛尔（SL 75212）对心血管的影响。
8. Use Of Colistin Serum Concentrations After Intravenous Administration Of Colistimethate Sodium To Determine Pharmacokinetic And Pharmacodynamic Relationships [R] . Byers, D. 2011

机译：静脉注射Colistimethate钠后使用粘菌素血清浓度来确定药代动力学和药效学关系

Blood concentrations and pharmacodynamic effects of betaxolol (SL 75212) a new beta-adrenoceptor antagonist after oral and intravenous administration.

著录项

相似文献

相关主题

期刊订阅